OS and PFS of the whole patient dataset. Median follow-up was equal to 12 months and these patients presented (A) a median PFS of 9 months, and (B) a median OS of 13 months, with 32 (54%) patients still alive at the last follow-up examination. OS, overall survival; PFS, progression free survival; SD, standard deviation.